Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Musculoskeletal

Osteoarthritis

Reviewed September 29, 2026

The largest genetic study of osteoarthritis, in 1,962,069 people, found 962 associations and named 700 genes likely to act in the joint. 62 of the positions it reports are in this catalogue — and 51 of them were already here for something else, from height to body weight.

What this condition connects to

Prevalence
Estimated to reach 1 billion people worldwide by 2050, and the third most rapidly growing health condition associated with disability after dementia and diabetes, as the study behind this page states. The study combined up to 489,975 cases and 1,472,094 controls (Hatzikotoulas et al. 2025, PMID:40205036).
Inheritance
Polygenic: 962 independent associations in the largest study, 62 of its reported positions on this page, each common variant of small effect. Rare coding variants in the study's effector genes carried consistently larger effects than common variants.

Osteoarthritis is the gradual breakdown of a joint — the cartilage first, then the bone and tissue around it — bringing pain, stiffness and loss of movement. It is the third most rapidly growing health condition associated with disability, after dementia and diabetes, and the number of people living with it is estimated to reach 1 billion by 2050. No treatment yet changes the course of the disease.

1,962,069 people, 962 associations

Hatzikotoulas et al. 2025, in Nature, combined genome-wide association studies of up to 489,975 people with osteoarthritis and 1,472,094 without. It established 962 independent associations, 513 of them not reported before. The study looked at osteoarthritis as a whole and joint by joint — hip, knee, hand, finger, thumb and spine — and separately at people whose hip or knee had been replaced.

Using gene activity, protein and epigenetic profiles from joint tissue itself, the authors named 700 effector genes: the genes most likely to be doing the work at those positions. 10% of them make a protein that an approved drug already targets. That is the practical point of the paper — a list of existing medicines that might be repurposed for a disease that has none of its own. Rare protein-altering variants in the effector genes had consistently larger effects than the common variants did.

What the genes have in common

The signal was concentrated in the pathways of embryonic skeletal development — the programmes that build the skeleton before birth. The study highlights eight biological processes in which several effector genes converge, among them the circadian clock, processes related to glial cells, the organisation of the extracellular matrix, and signalling pathways with an established role in osteoarthritis: TGFβ, FGF, WNT, BMP and retinoic acid.

62 positions, and where they were filed before

This catalogue holds 62 of the positions the study reports. Only 11 are filed on this site under osteoarthritis. The other 51 were already here under another trait — height, body weight, blood lipids, bone density — and the study reports the same positions for osteoarthritis.

Height is the clearest case. rs224333 in GDF5, a growth factor of the BMP family that helps form joints, is filed here under height; the study reports it for knee osteoarthritis. rs3817428 is a protein-altering variant in ACAN, the gene for aggrecan, a main structural molecule of cartilage. rs75621460 in TGFB1 and rs4073717 in FGF18 sit in two of the signalling families the study names. rs10832027 lies in BMAL1 (listed on this site as ARNTL), a core gene of the circadian clock. Three positions in FTO — rs1421085, rs1558902 and rs9941349 — are filed here under obesity, and body weight is an established risk for osteoarthritis. The abstract gives the number of effector genes, not their names, so this page does not say which of these genes are on that list.

One joint or several

Earlier, smaller studies are the basis of this site's pages on knee osteoarthritis and hip osteoarthritis. In this study's records some positions appear for more than one joint — rs75621460 is recorded for both hip and knee — and others for one only: rs11550348 in IRF2BP1 is recorded for the finger, and rs11588850 in SNAP47 for the thumb. The bones topic collects what this site holds on the skeleton.

From our blog

A height chart on a wall, with two of its marks leading off to a knee and to the abdominal wall

Your Height Genes Have Second Jobs: Meet GDF5 and EFEMP1

The stretches of DNA that set your height do other work too. In the records of three large studies, the taller…

Clinical detail

What is actually diagnosed and treated here

Osteoarthritis is diagnosed from symptoms and examination, with X-ray where needed — not from a genotype. None of the 62 variants on this page is used by any guideline to predict, screen for or diagnose osteoarthritis.

Each common variant here shifts the odds by a small amount, and the study's purpose was to find the biology and the drug targets, not to predict individuals. Age, previous joint injury and body weight are what a clinician weighs. Exercise, weight management and pain relief are the established care, and joint replacement is the treatment when a hip or knee has failed. A drug that slows the disease itself does not yet exist; the study's list of approved drugs with a target among its effector genes is a starting point for trials, not a result from one.

Which ancestries this evidence comes from

The studies behind these variants recruited participants from different ancestries — a result found in one population doesn't always transfer to another. Based on 45 of 319 linked studies with a resolved discovery ancestry.

European · 10.3% East Asian · 1.6% Other named ancestries (NR, African unspecified, Asian unspecified, Other, African American or Afro-Caribbean,European, European,NR, African American or Afro-Caribbean, South Asian, Hispanic or Latin American) · 2.2% Not yet resolved · 85.9%

Sources

Databases, guidelines and references

Papers, with their authors

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Osteoarthritis. MyGeneLog™. https://www.mygenelog.com/conditions/osteoarthritis

Questions about Osteoarthritis

What is osteoarthritis?

The gradual breakdown of a joint — cartilage first, then the bone and tissue around it — causing pain, stiffness and loss of movement. It is the third most rapidly growing health condition associated with disability, after dementia and diabetes.

Is osteoarthritis genetic?

Partly. The largest genetic study, in 1,962,069 people, established 962 independent associations and named 700 genes likely to act in the joint. Each common variant has a small effect; age, injury and body weight matter as well.

Why are height and body weight variants on an osteoarthritis page?

Because the study reports the same positions for osteoarthritis. Of the 62 positions on this page, 51 were already in this catalogue under another trait, and the study found its signal concentrated in the pathways that build the skeleton before birth.

Can these variants predict whether I will get osteoarthritis?

No. They are population-level findings of small effect. Osteoarthritis is diagnosed from symptoms and examination, and no guideline uses a genotype to predict it.

Free to reuse, non-commercially. This page's text is original writing from freely-available research, licensed CC BY-NC 4.0 — share and adapt it with attribution to MyGeneLog™; commercial use is licensed. It's general research-derived information, not medical advice or a diagnosis — see Terms of Use.